An AAV-CRISPR/Cas9 gene editing approach for GUCY2D-associated cone rod dystrophy (CORD6)

被引：0
|
作者：
Mccullough, Kevin [1 ]
Boye, Sanford L. [1 ]
Fajardo, Diego [1 ]
Strang, Christianne E. [2 ]
Witherspoon, Douglas C. [2 ]
Gloskowski, Sebastian [3 ]
Dass, Abhishek [3 ]
Gamlin, Paul D. [2 ]
Maeder, Morgan [3 ]
Boye, Shannon Elizabeth [1 ]
机构：
[1] Univ Florida, Ophthalmol, Gainesville, FL USA
[2] Univ Alabama Birmingham, Birmingham, AL USA
[3] Editas Med Inc, Cambridge, MA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
6020
引用
收藏
页数：3
相关论文
共 32 条
  • [1] An AAV-CRISPR/Cas9 Gene Editing Approach for GUCY2D-Associated Cone Rod Dystrophy (CORD6)
    Mellen, R. W.
    McCullough, K. T.
    Boye, S. L.
    Fajardo, D.
    Strang, C. E.
    Witherspoon, C. D.
    Hill, J. L.
    Gloskowski, S. W.
    Dass, A.
    Gamlin, P. D.
    Maeder, M. L.
    Boye, S. E.
    MOLECULAR THERAPY, 2019, 27 (04) : 429 - 429
  • [2] AAV-CRISPR/Cas9 Gene Editing is Therapeutic in a Novel, Humanized Mouse Model of GUCY2D-Associated Cone Rod Dystrophy (CORD6)
    Mellen, Russell W.
    McCullough, K. Tyler
    Fajardo, Diego
    Calabro, Kaitlyn
    Crosson, Sean
    Xu, Emily
    Boye, Sanford L.
    Boye, Shannon E.
    MOLECULAR THERAPY, 2022, 30 (04) : 566 - 566
  • [3] Systemic Gene Editing for Muscular Dystrophy Using AAV-CRISPR/Cas9
    Bengtsson, Niclas E.
    Hall, John K.
    Chamberlain, Jeffrey S.
    MOLECULAR THERAPY, 2017, 25 (05) : 16 - 16
  • [4] Development of a Novel Cone-Rod Dystrophy 6 (CORD6) Mouse Model to Assess AAV-CRISPR/Cas9-Based Therapies
    Mellen, Russell W.
    Boye, Sanford L.
    McCullough, K. Tyler
    Fajardo, Diego
    Crosson, Sean
    Calabro, Kaitlyn
    Dizhoor, Alex M.
    Boye, Shannon E.
    MOLECULAR THERAPY, 2020, 28 (04) : 267 - 267
  • [5] Somatic Gene Editing of GUCY2D by AAV-CRISPR/Cas9 Alters Retinal Structure and Function in Mouse and Macaque
    McCullough, K. Tyler
    Boye, Sanford L.
    Fajardo, Diego
    Calabro, Kaitlyn
    Peterson, James J.
    Strang, Christianne E.
    Chakraborty, Dibyendu
    Gloskowski, Sebastian
    Haskett, Scott
    Samuelsson, Steven
    Jiang, Haiyan
    Witherspoon, C. Douglas
    Gamlin, Paul D.
    Maeder, Morgan L.
    Boye, Shannon E.
    HUMAN GENE THERAPY, 2019, 30 (05) : 571 - 589
  • [6] AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9
    Li, Ang
    Tanner, Mark R.
    Lee, Ciaran M.
    Hurley, Ayrea E.
    De Giorgi, Marco
    Jarrett, Kelsey E.
    Davis, Timothy H.
    Doerfler, Alexandria M.
    Bao, Gang
    Beeton, Christine
    Lagor, William R.
    MOLECULAR THERAPY, 2020, 28 (06) : 1432 - 1441
  • [7] AAV-CRISPR Gene Editing is Negated by Pre-Existing Immunity to Cas9
    Li, Ang
    Lee, Ciaran M.
    Tanner, Mark R.
    Hurley, Ayrea E.
    De Giorgi, Marco
    Jarrett, Kelsey E.
    Davis, Timothy H.
    Doerfler, Alexandria M.
    Bao, Gang
    Beeton, Christine
    Lagor, William R.
    MOLECULAR THERAPY, 2020, 28 (04) : 565 - 566
  • [8] A natural history study of GUCY2D-associated cone-rod dystrophy
    Scopelliti, Amanda
    Jamieson, Robyn
    Rajagopalan, Sulekha
    Grigg, John
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 49 (08): : 905 - 905
  • [9] A natural history study of autosomal dominant GUCY2D-associated cone–rod dystrophy
    Amanda J. Scopelliti
    Robyn V. Jamieson
    Elizabeth H. Barnes
    Benjamin Nash
    Sulekha Rajagopalan
    Elisa L. Cornish
    John R. Grigg
    Documenta Ophthalmologica, 2023, 147 : 189 - 201
  • [10] Promoter Orientation within an AAV-CRISPR Vector Affects Cas9 Expression and Gene Editing Efficiency
    Fry, Lewis E.
    Peddle, Caroline F.
    Stevanovic, Marta
    Barnard, Alun R.
    McClements, Michelle E.
    MacLaren, Robert E.
    CRISPR JOURNAL, 2020, 3 (04): : 276 - 283
1234